Podcasts > Archived Podcasts > Market Foolery
Market Foolery
More Volatility, More Fed Action
Investors react to Monday’s 13% decline in the market. The Federal Reserve introduces emergency lending programs. And shares of Regeneron Pharmaceuticals rise after the biotech company announces that it aims to have a potential drug for COVID 19 ready for trials this summer. Motley Fool analyst Jason Moser discusses those stories and share his investing approach during these volatile times.
Thanks to Molekule for supporting our channel. Get 10% off your first air purifier at http://www.molekule.com/" id="LPlnk550840" name="LPlnk550840" rel="noopener noreferrer" style="margin: 0px; padding: 0px; border: 0px; font: inherit; vertical-align: baseline; color: purple; text-decoration: underline;" target="_blank">http://www.molekule.com with code fool10.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.